News & Analysis on Clinical Trial Services & Contract Research And Development
Outsourcing company, Covalent Group, has announced the signing of a $2.1M (€1.7M) contract to provide a range of services to support the research and development of new therapies to treat hyponatremia.
Outsourcing-Pharma focus on: cutting the cost of clinical trials
As pharma companies flock towards Eastern Europe and India in a bid to cut direct clinical trial costs, does outsourcing actually translate into real world cost-savings?
Scientists have made available a powerful new tool for studying brain development, which will help scientists discover the genetic origins of brain cancers, which could speed development of novel drugs to treat them.
Affymetrix introduces its new ChIP-On-Chip array product line that its designers hope will provide drug researchers with new whole-genome tools to assist scientists discover DNA-Protein interactions.
inVentiv Health (Formerly Ventiv Health) saw its fourth quarter profits dive in 2005 by 37 per cent after being hit by higher interest expenses and an income tax provision, however, the company managed to increase its sales for the quarter by 49 per...
Researchers have discovered a series of enzyme inhibitors that appear to block the replication of the SARS virus - a finding that could help speed up the research and development of drugs used to treat the killer virus.
New diabetes trials scheduled to start this spring have been heralded as groundbreaking as researchers aim to reverse juvenile diabetes of which numbers have been steadily on the rise in developed nations.